· Generic drug consistency evaluation products
· National medical insurance, national essential drug varieties
· The drug of choice for refractory psychosis
· Self-produced raw materials

Specification: 25mg丨50mg
Drug category: Western medicine
National Health Insurance: Category A

Indications: Refractory schizophrenia.

Pharmacology and Toxicology: This is a dibenzodiazepine antipsychotic drug. It has a strong blocking effect on 5-hydroxytryptamine (5-HT2A) receptors and dopamine (DA1) receptors in the brain, also has a blocking effect on dopamine (DA4) receptors, and blocks dopamine (DA2) receptors. The stagnation effect is weak, in addition to anticholinergic (M1), antihistamine (H1) and anti-A-adrenergic receptor effects, extrapyramidal reactions are rare, and generally do not cause increased blood prolactin. It can directly inhibit the upward activation system of the brainstem reticular structure, and has a strong sedative and hypnotic effect.